Education
About Us
Working with TipRanks
Follow Us
Solventum Corporation (SOLV)
:SOLV
SOLV Stock Chart & Stats
$80.68
-$0.47(-0.68%)
At close: 4:00 PM EST
$80.68
-$0.47(-0.68%)
Day’s Range― - ―
52-Week Range$60.70 - $88.20
Previous CloseN/A
Volume531.14K
Average Volume (3M)1.14M
Market Cap
$14.15B
Enterprise Value$16.30B
Total Cash (Recent Filing)$1.64B
Total Debt (Recent Filing)$5.14B
Price to Earnings (P/E)9.4
Beta0.59
Next Earnings
Feb 26, 2026EPS Estimate
1.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.50
Shares Outstanding173,447,560
10 Day Avg. Volume1,146,141
30 Day Avg. Volume1,142,390
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)3.87
Price to Sales (P/S)1.39
P/FCF Ratio14.21
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue1.94
Enterprise Value/Gross Profit3.55
Enterprise Value/Ebitda6.29
Forecast
1Y Price Target
$91.29Price Target Upside13.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)6.02
Revenue Forecast (FY)$8.25B
Bulls Say, Bears Say
Bulls Say
Long-term Cost SavingsSOLV's strong execution and foresight into getting ahead of 2026 concerns with a new $500M long-term cost saving program is noteworthy.
Mergers And AcquisitionsSOLV announced a definitive agreement to acquire Acera Surgical for ~$725M cash and up to $125M in contingent cash payments based on the achievement of certain future milestones.
Share RepurchaseSOLV also announced a ~$1B share repurchase program which is expected to begin in FY26.
Bears Say
Ownership And Share Pressure3M ownership stands at 14.75%, and it's likely that they will reduce their position through coordinated secondary offerings, which could depress shares.
Post-Spin RisksThere is risk around post-spin separation activities which could impact quarterly results in FY26.
Tariff HeadwindsSOLV expects an ~$60M to ~$80M pre-tax tariff headwind impacting EPS.
Solventum Corporation News
SOLV FAQ
What was Solventum Corporation’s price range in the past 12 months?
Solventum Corporation lowest stock price was $60.70 and its highest was $88.20 in the past 12 months.
What is Solventum Corporation’s market cap?
Solventum Corporation’s market cap is $14.15B.
When is Solventum Corporation’s upcoming earnings report date?
Solventum Corporation’s upcoming earnings report date is Feb 26, 2026 which is in 67 days.
How were Solventum Corporation’s earnings last quarter?
Solventum Corporation released its earnings results on Nov 06, 2025. The company reported $1.5 earnings per share for the quarter, beating the consensus estimate of $1.43 by $0.07.
Is Solventum Corporation overvalued?
According to Wall Street analysts Solventum Corporation’s price is currently Undervalued.
Does Solventum Corporation pay dividends?
Solventum Corporation does not currently pay dividends.
What is Solventum Corporation’s EPS estimate?
Solventum Corporation’s EPS estimate is 1.49.
How many shares outstanding does Solventum Corporation have?
Solventum Corporation has 173,447,560 shares outstanding.
What happened to Solventum Corporation’s price movement after its last earnings report?
Solventum Corporation reported an EPS of $1.5 in its last earnings report, beating expectations of $1.43. Following the earnings report the stock price went up 7.906%.
Which hedge fund is a major shareholder of Solventum Corporation?
Currently, no hedge funds are holding shares in SOLV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solventum Corporation Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$91.29 (13.15% Upside)
$91.29 (13.15% Upside)
Blogger Sentiment
Bullish
SOLV Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 3.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.2%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.14%
12-Months-Change
Fundamentals
Return on Equity
37.25%
Trailing 12-Months
Asset Growth
-5.24%
Trailing 12-Months
Company Description
Solventum Corporation
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
SOLV Company Deck
SOLV Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Solventum reported strong sales growth, successful portfolio optimization, and a transformed balance sheet, positioning the company for future growth and acquisitions. However, tariff headwinds and segment-specific challenges pose risks. Overall, the highlights significantly outweigh the lowlights, reflecting a positive outlook.View all SOLV earnings summariesSOLV Stock 12 Month Forecast
Average Price Target
$91.29
▲(13.15% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Encompass Health
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
14.88% Insiders
18.88% Mutual Funds
27.58% Other Institutional Investors
17.99% Public Companies and
Individual Investors